Attitudes towards open-label versus placebo-control designs in oncology randomized trials: A survey of medical oncologists

Igal Kushnir*, Mark Clemons, Dean Fergusson, Dominick Bossé, Martin Neil Reaume

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Attitudes towards open-label versus placebo-control designs in oncology randomized trials: A survey of medical oncologists'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science